纤维蛋白胶复合平阳霉素栓塞硬化治疗面颈部动静脉畸形效果观察

doi:10.19438/j.cjoms.2018.01.011

中国口腔颌面外科杂志 ›› 2018, Vol. 16 ›› Issue (1): 52-55.doi: 10.19438/j.cjoms.2018.01.011

纤维蛋白胶复合平阳霉素栓塞硬化治疗面颈部动静脉畸形效果观察

闫志伟¹, 张春谊¹, 郭军², 杨霞¹, 王维戚¹, 杨涛¹, 孙沫逸¹, 杨耀武¹

1.军事口腔医学国家重点实验室,口腔疾病国家临床医学研究中心,陕西省口腔疾病临床医学研究中心, 第四军医大学口腔医学院头颈肿瘤外科,2.B超室,陕西西安 710032

收稿日期:2017-07-04 修回日期:2017-11-18 出版日期:2018-01-20 发布日期:2018-02-11
通讯作者: 杨耀武,E-mail：yangyaowu_1@sina.com
作者简介:闫志伟（1980-）,男,博士研究生,E-mail：gewwanyan@foxmail.com
基金资助:
国家自然科学基金（81470757）

Clinical observation of fibrin glue combined with pingyangmycin for the embolism and sclerotherapy of cervicofacial arteriovenous malformations

YAN Zhi-wei¹, ZHANG Chun-yi¹, GUO Jun², YANG Xia¹, WANG Wei-qi¹, Yang Tao¹, SUN Mo-yi¹, YANG Yao-wu¹

1.Department of Head and Neck Tumor Surgery, 2. B-Ultrasound Room, School of Stomatology, The Fourth Military Medical University; State Key Laboratory of Military Stomatology & National Clinical Research Center for Oral Diseases & Shaanxi Clinical Research Center for Oral Diseases. Xi'an 710032, Shaanxi Province, China

Received:2017-07-04 Revised:2017-11-18 Online:2018-01-20 Published:2018-02-11

摘要/Abstract

摘要： 目的: 观察和评价纤维蛋白胶复合平阳霉素栓塞硬化治疗面颈部动静脉畸形的临床效果。方法: 2012年12月—2016年12月,选择22例面颈部动静脉畸形病例,应用纤维蛋白胶复合平阳霉素栓塞硬化技术进行治疗。其中15例患者给予单纯经皮穿刺直接注射治疗,2例患者除原发灶区经皮穿刺直接注射外,同时行面动脉注射治疗,6例患者栓塞硬化治疗完成后,手术切除病变区增厚的纤维结缔组织及残余病变。治疗后观察患者生命体征,体格检查、彩色多普勒超声及CT、CTA评价治疗效果。随访时间6~36个月（平均18个月）。结果: 22例患者中,男17例,女5例;年龄19~74岁（平均28岁）。18例（81.8%）患者病变消退率大于90%,4例（18.2%）病变消退率大于50%。治疗过程中,部分患者出现皮肤发白或青紫色改变,提示组织缺血或回流受阻。1例患者额部出现皮肤浅层坏死,局部形成薄痂;2例患者出现唇黏膜浅溃疡,均自行愈合。随访发现,3例患者病变继续生长。结论: 纤维蛋白胶复合平阳霉素栓塞硬化技术用于治疗面颈部动静脉畸形安全、有效,尤其对局限性扩张型动静脉畸形效果较好。

关键词: 动静脉畸形, 平阳霉素, 纤维蛋白胶, 硬化治疗, 栓塞

Abstract: PURPOSE: To observe and evaluate the outcome of fibrin glue (FG) combined with pingyangmycin (PYM) for treatment of selected cervicofacial arteriovenous malformation (AVM). METHODS: Twenty-two patients with cervicofacial AVM were chosen and treated by embolism and sclerotherapy of FG combined with PYM from December 2012 to December 2016. Of the 22 cases, 15 underwent a direct percutaneous puncture of the nidus and injection of FG combined with PYM solely; 2 underwent an injection of FG combined with PYM into the facial artery in addition to direct injection in lesion. Six underwent surgical excision of the redundant fibrous connective tissue and residual lesions after the embolism and sclerotherapy. To observe the vital signs and symptoms after treatments. The therapeutic effect was evaluated by physical examination, ultrasonography with Doppler, computed tomography (CT) scan, and CT angiography. The follow-up time was from 6 months to 36 months(mean 18 months). RESULTS: Of 22 patients, 17 were male and 5 were female, ranging in age from 19~74 years（mean,28 years）. Eighteen of 22 lesions (81.8%) showed greater than 90% reduction, whereas another 4 (18.2%) exhibited greater than 50% reduction. Transient white or cyan purple alteration in the skin occurred during the course treatment, indicating tissue ischemia or obstruction of draining veins. Superficial skin necrosis occurred and thin crust formed in forehead of 1 patient, and superficial mucous ulcer occurred in 2 patients and healed on its own. Three patients were found to continue growth during follow-up. CONCLUSIONS: Application of fibrin glue combined with PYM for the embolism and sclerotherapy of selected cervicofacial AVM appears to be safe and effective. It offers broad prospects especially for the treatment of locally expanded AVM.

Key words: Arteriovenous malformations, Pingyangmycin, Fibrin glue, Sclerotherapy, Embolism

中图分类号:

R782.2

闫志伟, 张春谊, 郭军, 杨霞, 王维戚, 杨涛, 孙沫逸, 杨耀武. 纤维蛋白胶复合平阳霉素栓塞硬化治疗面颈部动静脉畸形效果观察[J]. 中国口腔颌面外科杂志, 2018, 16(1): 52-55.

YAN Zhi-wei, ZHANG Chun-yi, GUO Jun, YANG Xia, WANG Wei-qi, Yang Tao, SUN Mo-yi, YANG Yao-wu. Clinical observation of fibrin glue combined with pingyangmycin for the embolism and sclerotherapy of cervicofacial arteriovenous malformations[J]. China J Oral Maxillofac Surg, 2018, 16(1): 52-55.

参考文献

[1] Yang Y, Sun M, Hou R, et al.Preliminary study of fibrin glue combined with pingyangmycin for the treatment of venous malformations in the oral and maxillofacial region[J]. J Oral Maxillofac Surg, 2008, 66(11): 2219-2225.
[2] 杨擎天, 杨耀武, 孙沫逸, 等. 纤维蛋白胶复合平阳霉素栓塞硬化治疗面颈部静脉畸形的远期疗效观察[J]. 中国口腔颌面外科杂志, 2013, 11(3): 238-242.
[3] Enjolras O, Logeart I, Gelbert F, et al.Arteriovenous malformations: A study of 200 cases[J]. Ann Dermatol Venereol, 2000, 127(1): 17-22
[4] Kohout MP, Hansen M, Pribaz JJ, et al.Arteriovenous malformations of the head and neck: natural history and management[J]. Plast Reconstr Surg, 1998, 102(3): 643-654.
[5] Liu AS, Mulliken JB, Zurakowski D, et al.Extracranial arteriovenous malformations: natural progression and recurrence after treatment[J]. Plast Reconstr Surg, 2010, 125(4): 1185-1194.
[6] 杨耀武, 雷德林, 程晓兵, 等. 射频消融术用于治疗面颈部脉管畸形[J]. 实用口腔医学杂志, 2011, 27(4): 527-530
[7] Dupuis-Girod S, Ginon I, Saurin J, et al.Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output[J]. JAMA, 2012, 307(9): 948-955.
[8] Fowell C, Jones R, Nishikawa H, et al.Arteriovenous malformations of the head and neck: current concepts in management[J]. Br J Oral Maxillofac Surg, 2016, 54(5): 482-487.
[9] 范新东, 郑连洲. 头颈部血管瘤及血管畸形的诊断和介入治疗[J]. 中国眼耳鼻喉科杂志, 2012, 12(3): 137-144.
[10] Su L, Wang D, Han Y, et al.Absolute ethanol embolization of infiltrating-diffuse extracranial arteriovenous malformations in the head and neck[J]. Eur J Vasc Endovasc Surg, 2015, 50(1):114-121.
[11] Zhao XP, Huang ZQ, Chen WL, et al.Percutaneous sclerotherapy of arteriovenous malformations of the face using fibrin glue combined with OK-432 and bleomycin after embolisation[J]. Br J Oral Maxillofac Surg, 2016, 54(2): 187-191.
[12] Yakes WF, Yakes AM.The Yakes classification of arteriovenous malformations [R]. New York: The 40th Annual Veith Symposium Presentation, 2013.

[1]	邰茂众, 陈涛, 李克雷, 葛春晓, 徐振国, 秦中平. 2种病变内平阳霉素注射方法治疗68例儿童唇面部微囊型淋巴管畸形疗效分析[J]. 中国口腔颌面外科杂志, 2022, 20(3): 268-272.
[2]	吴海威, 于淼, 郑家伟. 口腔颌面部静脉畸形诊治：经验与进展[J]. 中国口腔颌面外科杂志, 2021, 19(2): 186-192.
[3]	靳能皓, 南欣荣, 闫星泉, 李明. 手术结合平阳霉素注射治疗巨舌症1例报告[J]. 中国口腔颌面外科杂志, 2020, 18(2): 190-192.
[4]	张涵恕, 刘少华, 郑家伟. 聚多卡醇治疗血管瘤及脉管畸形研究进展[J]. 中国口腔颌面外科杂志, 2020, 18(1): 77-81.
[5]	吴丹媚, 黄磊, 刘法鑫, 白植宝. 左颈根部乳糜囊肿的诊断与治疗：附1例报告[J]. 中国口腔颌面外科杂志, 2019, 17(5): 478-480.
[6]	刘学键, 刘志鹏, 武宜雷, 邰茂众. 平阳霉素新剂型瘤体内注射治疗婴幼儿血管瘤203例临床分析[J]. 中国口腔颌面外科杂志, 2019, 17(3): 247-250.
[7]	雷书赞, 汪接兵, 张银喜. 气管切开全麻下无水乙醇栓塞治疗咽喉部静脉畸形20例报道[J]. 中国口腔颌面外科杂志, 2019, 17(1): 74-76.
[8]	中华口腔医学会口腔颌面外科专业委员会脉管性疾病学组. 聚桂醇硬化剂治疗口腔颌面部血管瘤和脉管畸形专家共识[J]. 中国口腔颌面外科杂志, 2018, 16(3): 275-278.
[9]	顾玲, 黄迪炎, 付崇建, 王昭领, 王栋, 杨璐, 朱国雄. 平阳霉素联合激素治疗肉芽肿性唇炎的临床疗效评价[J]. 中国口腔颌面外科杂志, 2018, 16(2): 157-161.
[10]	黄子贤, 陈耀庭, 李世豪, 范松, 张大明, 汪延, 严凌健, 陈伟良, 黄志权. 4例儿童期颌骨动静脉畸形血管复通的再治疗[J]. 中国口腔颌面外科杂志, 2017, 15(4): 329-333.
[11]	黄子贤，陈耀庭，李世豪，范松，张大明，汪延，严凌健，陈伟良，黄志权. 4例儿童期颌骨动静脉畸形血管复通的再治疗[J]. 中国口腔颌面外科杂志, 2017, 15(4): 368-372.
[12]	辜健敏, 孟箭, 顾倩平, 张杰, 李志萍, 王兴. 射频消融技术联合DSA引导下无水乙醇介入治疗口腔颌面部难治性动静脉畸形的疗效观察[J]. 中国口腔颌面外科杂志, 2017, 15(2): 157-160.
[13]	秦泽曼, 黄志权, 陈伟良, 赵小朋, 陈睿. 生物胶联合OK-432及博莱霉素治疗颌面部软组织动静脉畸形13例临床分析[J]. 中国口腔颌面外科杂志, 2017, 15(1): 73-76.
[14]	韩一峰, 范新东. 无水乙醇介入治疗头颈部囊性病变的临床应用现状[J]. 中国口腔颌面外科杂志, 2015, 13(2): 187-189.
[15]	沈时岳;邬腊梅;杨宏宇;罗娟;王锋;苏铭扬;. 小剂量平阳霉素早期干预婴幼儿腮腺血管瘤疗效分析 [J]. 中国口腔颌面外科杂志, 2013, 11(4): 340-344.

纤维蛋白胶复合平阳霉素栓塞硬化治疗面颈部动静脉畸形效果观察

Clinical observation of fibrin glue combined with pingyangmycin for the embolism and sclerotherapy of cervicofacial arteriovenous malformations

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价